Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)

N/ACompletedNCT02035865

Oslo University Hospital74 enrolled

Overview

The investigators aim at characterizing neuropsychiatric consequences of heart transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on mortality and cardiac allograft vasculopathy (CAV).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Psychiatric Diagnosis Cognition Disorders

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Participant in one of two former studies and heart transplanted at the time of inclusion into this former study Exclusion Criteria: * Cognitively not capable to consent to participation and/or * Insufficient fluent in the Norwegian language to complete both psychiatric and neuropsychological assessment

Locations (1)

Oslo University Hospital

Oslo, Norway

Outcomes

Primary Outcomes

Psychiatric morbidity

Psychiatric diagnoses by clinician and self-rapport

Time frame: At time of enrollment

Cognitive function

Neuropsychological assessment

Time frame: At time of enrollment

Secondary Outcomes

All cause mortality

Time since enrollment in former study; i.e. approximately 14 years (study 1) and approximately 3 years (study 2)

Time frame: 14 and 3 years respectively

Cardiac allograft vasculopathy

Time since enrollment in former study; i.e. approximately 14 years (study 1) and approximately 3 years (study 2)

Time frame: 14 and 3 years respectively

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.